Download DEB 2016_Preliminary Programme_2016_08_19

International
3rd DEB
Symposium
European Drug Eluting
Balloon Consensus Group
14–15 October 2016
www.deb-symposium.de
PROGRAMME
Berlin
© Sergey Nivens - 144482908/popmarleo - 86400313 - shutterstock.com
Table of Contents
Resolute Onyx™
Zotarolimus-Eluting Coronary Stent System
BROADEST SIZE MATRIX
INCLUDING COMPLEXLV
4.5
5.0
mm
AND
THE MAIN
SOLUTION
Resolute Onyx™ DES now brings its advanced
workhorse performance to left main stenting—
providing the size, strength and conformability
to help more patients heal.
www.medtronicstents.com
www.theadvancedworkhorse.com
© 2016 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic.
All other brands are trademarks of a Medtronic company. For distribution only in markets where the Resolute Onyx™
coronary stent has been approved. Not for distribution in the USA, Japan or France. UC201606085ML-01 2/16
mm
Table of Contents
Organisation and Imprint .......................................................................................... 4
Welcome Note of the Symposium Chairs.................................................................. 5
General Information................................................................................................... 6
Sponsors and Exhibitors............................................................................................. 7
Scientific Programme
Friday, 14 October 2016 .............................................................................. 8
Saturday, 15 October 2016 ......................................................................... 11
Index of Speakers, Discussants and Session Chairs................................................... 14
The 3rd International DEB Symposium is organised under the auspices of the:
Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V.
Design and Layout
Layout
Print
Circulation
Editorial Deadline
krea.tif-art UG (haftungsbeschränkt)
www.xxx.de
xx
xx xx xxxx
3
Organisation and Imprint
Venue Langenbeck-Virchow-Haus
Luisenstraße 58 • 10117 Berlin (DE)
Date
14–15 October 2016
Symposium Website
www.deb-symposium.de
Organiser
European Drug Eluting Balloon Consensus Group
Symposium Chairs
Univ.-Prof. Dr. med. Franz X. Kleber
Cardio Centrum Berlin
Academic Teaching Institution
Charité University Medicine
Berlin (DE)
Prof. Dr. med. Bruno Scheller
Saarland University Medical Center
Homburg (DE)
Scientific Organising Committee
Dr. Fernando Alfonso
Hospital Universitario de La Princesa
Madrid (ES)
Univ.-Prof. Dr. med. Franz X. Kleber
Charité University Medicine
Berlin (DE)
Bernardo Cortese
A.O. Fatebenefratelli Hospital Milan
Milan (IT)
Prof. Dr. med. Bruno Scheller
Saarland University Medical Center
Homburg (DE)
Dr. Simon Eccleshall
Norfolk and Norwich University Hospital
Norwich (GB)
Prof. Dr. med. Gunnar Tepe
RoMed Hospital Rosenheim
Rosenheim (DE)
Prof. Dr. Raban Jeger
University Hospital of Basel
Basel (CH)
for the European Consensus Group on Drug Coated Balloons
Symposium Organisation
Conventus Congressmanagement & Marketing GmbH
Marlen Schiller/Carl Haubold
Carl-Pulfrich-Straße 1 • 07745 Jena (DE)
Phone +49 3641 31 16-358/-276 • Fax +49 3641 31 16-243
[email protected] • www.conventus.de
4
Welcome Note of the Symposium Chairs
Dear Colleagues,
interventional cardiology is an ever changing field. Having established modern drug
eluting stents with biocompatibel or bioresorbable surface coating and bioresorbale
scaffolds the field is rapidly moving forward challenging coronary artery disease with
stentless angioplasty.
In the 3rd International Symposium on Drug Coated Balloons we will discuss this field
with most of the leading scientists and the leading clinical investigators in the field from
all over the world. Our aim is establishing a worldwide consensus on indications and
mode of application as well as to stimulate further research.
All are invited for an active part in this field. We are most happy to welcome you. Berlin
will host this event with an open atmosphere and a lively communication tradition.
Franz Xaver Kleber
Bruno Scheller
5
General Information
Registration
Registration for the symposium is free of charge.
Please register online at www.deb-symposium.de.
Opening Hours
Check In/
Speakers Ready Room
Industrial Exhibition
Friday
12.00–20.00
Saturday
07.30–13.00
12.30–21.00
07.30–13.30
Education Credits and Certification
… for attendants from Germany
The symposium is certified by the Medical Chamber of Berlin as follows:
14 October
15 October 6 Points 6 Points Category B
Category B
For certification all attendants are required to sign the certification list near the registration daily. Certificates of attendance may be picked up upon leaving the symposium at
the registration desk.
… for European attendants
The symposium is accredited by the European Board for Accreditation
in Cardiology (EBAC) for 9 hours of external CME credits.
Scientific Programme
14 October 2016 5 CME credits
15 October 2016 4 CME credits
Each participant should claim only those hours of credit that have actually been spent in
the educational activity. EBAC works according to the quality standards of the European
Accreditation Council for Continuing Medical Education (EACCME), which is an institution
of the European Union of Medical Specialists (UEMS).
Catering and Lunch
Tea, coffee, refreshments and snacks will be available free of charge during all programme
breaks within the industrial exhibition area.
Internet
A wireless internet access (wifi) is available in the building. Detailed information you will
receive at the registration desk.
6
Sponsors and Exhibitors
Sponsors
Gold Sponsor
B.Braun Melsungen AG
Vascular Systems
Berlin
Medtronic GmbH
Meerbusch
Silver Sponsor
Further Sponsor
Spectranetics Deutschland GmbH
Würzburg
Exhibitors
B.Braun Melsungen AG
Vascular Systems
Berlin
Boston Scientific Medizintechnik GmbH
Ratingen
Medtronic GmbH
Meerbusch
Spectranetics
Würzburg
State at printing
7
Scientific Programme • Friday, 14 October 2016
12.30–13.00
Coffee within the Industrial Exhibition
13.00–13.40Introduction
Room
Plenary Hall
Chair
Ran Kornowski (Petah Tikva/IR)
13.00
Opening
Franz X. Kleber (Berlin/DE), Bruno Scheller (Homburg/DE)
13.10
Quo vadis PCI
Ran Kornowski (Petah Tikva/IR)
13.25
History of drug coated balloon development
Ulrich Speck (Berlin/DE)
13.40–15.13
Room
Chairs
Co-Chair
Discussants
Session 1: The current state of DCB-PCI 1 – ISR
Plenary Hall
Fernando Alfonso (Madrid/ES), Bruno Scheller (Homburg/DE)
Amin Ariff Nuruddin (Kuala Lumpur/MY)
Harald Rittger (Fürth/DE), Bernardo Cortese (Milan/IT)
13.40
In stent restenosis – state of the art
Fernando Alfonso (Madrid/ES)
13.53
DES ISR round table discussion:
… stent is superior – Fernando Alfonso (Madrid/ES)
… DCB is superior – Bruno Scheller (Homburg/DE)
… DCB is equal – Robert A. Byrne (Munich/DE)
14.23
In stent restenosis – TLR in ISAR Desire and RIBS revisited
Bruno Scheller (Homburg/DE)
14.36
In stent restenosis – Japanese experience
Seiji Habara (Kurashiki/JP)
14.49
Neoatherosclerosis
Robert A. Byrne (Munich/DE)
15.01
Long term follow – Mortality benefit in ISR?
Harald Rittger (Fürth/DE)
8
Scientific Programme • Friday, 14 October 2016
15.13–16.01
Room
Chairs
Discussants
Session 2: The current state of DCB-PCI 2 – de novo
Plenary Hall
Azeem Latib (Milan/IT), Bernardo Cortese (Milan/IT)
Simon Eccleshall (Norwich/GB), Eun-Seok Shin (Ulsan/KR)
15.13
De novo – state of the art
Raban Jeger (Basel/CH)
15.25
De novo – In small vessels only?
Franz X. Kleber (Berlin/DE)
15.37
De novo – Bifurcations
Kenneth Chin (Kuala Lumpur/ MY)
15.49
De novo – What kind of proof do we need before we really use this
therapy in de novo
Azeem Latib (Milan/IT)
16.01–16.25
Room
Coffe Break within the Industrial Exhibition
Foyer
16.25–17.25
Room
Chairs
Discussants
Session 3: New studies, new indications 1 – de novo
Plenary Hall
Raban Jeger (Basel/CH), Simon Eccleshall (Norwich/GB)
Robert A. Byrne (Munich/DE), Piotr P. Buszman (Ustrom/PL)
16.25
DEB in patients with a high bleeding risk – registry study and
DEBUT RCT
Tuomas Rissanen (Joensuu/FI)
16.37
Japanese SVD study
Atsushi Funatsu (Kyoto/JP)
16.49
Leipzig Data
Madlen Uhlemann (Leipzig/DE)
17.01
All comers registry on 1025 pts
Mark Rosenberg (Kiel/DE)
17.13
International bifurcation registry
Leonhard Bruch (Berlin/DE)
9
Scientific Programme • Friday, 14 October 2016
17.25–18.13
Room
Chairs
Discussants
Session 4: Technical aspects 1
Plenary Hall
Wan Azman Wan Ahmad (Kuala Lumpur/MY)
Franz X. Kleber (Berlin/DE)
Mark Rosenberg (Kiel/DE), Bernardo Cortese (Milan/IT)
17.25
Predilatation and lesion preparation with scoring/cutting balloons
Robert A. Byrne (Munich/DE)
17.37
Dissection is what we need or what we fear?
Bernardo Cortese (Milan/IT)
17.49
Strategies to reduce the impact of dissection and recoil
Bruno Scheller (Homburg/DE)
18.01
The value of FFR measurement for the DCB decision
Eun-Seok Shin (Ulsan/KR)
18.13–19.05
Room
Chairs
Discussants
Session 5: Clinical and pathophysiological aspects
Plenary Hall
Bruno Scheller (Homburg/DE), Simon Eccleshall (Norwich/GB)
Wan Azman Wan Ahmad (Kuala Lumpur/MY)
Leonhard Bruch (Berlin/DE)
18.13
Importance of pharmocokinetics for clinical efficacy
Bruno Scheller (Homburg/DE)
18.26
Combination of DCB with DES and BVS
Azeem Latib (Milan/IT)
18.39
Vascular restoration 1 – vascular remodeling and healing
Tudor-Constantin Pörner (Jena/DE)
18.52
Vascular restoration 2 – plaque regression and redistribution
Eun-Seok Shin (Ulsan/KR)
20.00
Room
Get-Together
Foyer
10
Scientific Programme • Saturday, 15 October 2016
08.00–08.25Morning coffee within the Industrial Exhibition
Room
Foyer
08.30–09.40
Room
Chairs
Discussants
Session 6: New studies, new indications 2
Plenary Hall
Ulf Landmesser (Berlin/DE), Junbo Ge (Shanghai/CN)
Tuomas Rissanen (Joensuu/FI), Robert A. Byrne (Munich/DE)
08.30
New indications confirmed 2 – ACS and acute MI
Hee Hwa Ho (Singapure/SG)
08.45
DCB for CTO – New paradigm?
Houng Bang Liew (Kota Kinabalu/MY)
09.00
Mortality benefit – round table with discussion
... Introduction (Stent Thrombosis, Stent in Stent Thrombosis, TVR
with stents for de novo and ISR) – Simon Eccleshall (Norwich/GB)
... PEPCAD DES – Harald Rittger (Fürth/DE)
... PEPCAD China – Junbo Ge (Shanghai/CH)
... ISAR Desire III – Robert A. Byrne (Munich/DE)
... BELLO – Francesco Giannini (Milan/IT)
09.40–10.25
Room
Chairs
Discussants
Session 7: Technical aspects 2
Plenary Hall
Bruno Scheller (Homburg/DE), Franz X. Kleber (Berlin/DE)
Wan Azman Wan Ahmad (Kuala Lumpur/MY)
Mark Rosenberg (Kiel/DE)
09.40
Is there a geographic mismatch problem in de novo?
Bernardo Cortese (Milan/IT)
09.55
Is there an optimal luminal gain in de novo?
Atsushi Funatsu (Kyoto/JP)
10.10
Do large vessels respond any different?
Simon Eccleshall (Norwich/GB)
10.25–10.55
Room
Coffee Break within the Industrial Exhibition
Foyer
11
Scientific Programme • Saturday, 15 October 2016
10.55 – 12.10
Room
Chairs
Discussants
Session 8: Peripheral application
Plenary Hall
Gunnar Tepe (Rosenheim/DE), Francesco Liistro (Arzzo/IT)
Marianne Brodmann (Graz/AT)
Michael Werk (Berlin/DE)
Thomas Zeller (Bad Krozingen/DE
10.55
Epidemiology of and challenges in peripheral arterial disease
N.N.
11.10
DCB new standard of care in the SFA?
Michael Werk (Berlin/DE)
11.22
Calcified lesions – the role of vessel preparation
Gunnar Tepe (Rosenheim/DE)
11.34
BTK – reasons for DCB failure
Marianne Brodmann (Graz/AT)
11.46
DCB work in BTK – if you select the right patients and take care of
their wounds
Francesco Liistro (Arzzo/IT)
11.58
Unmet needs in peripheral interventions – future role of DCB
or other technologies
Thomas Zeller (Bad Krozingen/DE)
12.10 – 13.00
Room
Chairs
Discussants
Session 9: A glance into the future
Plenary Hall
Piotr P. Buszman (Ustrom/PL), Thomas Zeller (Bad Krozingen/DE)
Kenneth Chin (Kuala Lumpur/ MY)
12.10
DCB in a pediatric population
Hashim Abdul-Khaliq (Homburg/DE)
12.20
Sirolimus eluting DCBs, first experiences
Bruno Scheller (Homburg/DE)
12
Scientific Programme • Saturday, 15 October 2016
12.30
New carriers and new drugs
Ulrich Speck (Berlin/DE)
12.40
Statements of Chinese, Italian and Japanese consensus groups
Bernardo Cortese (Milan/IT)
Atsushi Funatsu (Kyoto/JP)
Junbo Ge (Shanghai/CN)
12.55
Adjourn, summary and publication strategy
Franz X. Kleber (Berlin/DE)
13.00
Room
Soup and Refreshments within the Industrial Exhibition
Foyer
Did you
know?
Conventus is the Professional Congress Organiser for the
3rd International DEB Symposium*
*European Drug Eluting Balloon Consensus Group
13
Index of speakers, discussants and session chairs
A
Hashim Abdul-Khaliq (Homburg/DE)
Fernando Alfonso (Madrid/ES)
B
Marianne Brodmann (Graz/AT)
Leonhard Bruch (Berlin/DE)
Piotr P. Buszman (Ustrom/PL)
Robert A. Byrne (München/DE)
12
8
12
9, 10
9, 12
8, 9
10, 11
C
Kenneth Chin (Kuala Lumpur/MY) 9, 12
Bernardo Cortese (Milan/IT) 8, 9, 10, 11,
13
E
Simon Eccleshall (Norwich/GB) 9, 10, 11
F
Atsushi Funatsu (Kyoto/JP)
G
Junbo Ge (Shanghai/CH)
Francesco Giannini (Milan/IT)
H
Seiji Habara (Kurashiki/JP)
Hee Hwa Ho (Singapore/SG)
J
Raban Jeger (Basel/CH)
9, 11, 13
11, 13
11
8
11
9
K
Franz X. Kleber (Berlin/DE) 8, 9, 10, 11, 13
Ran Kornowski (Hasharon /IR)
8
14
L
Uwe Landmesser (Berlin/DE)
11
Azeem Latib (Milan/IT)
9, 10
Houng Bang Liew (Kota Kinabalu/MY) 11
Francesco Liistro (Arezzo/IT)
12
N
Amin Ariff Nuruddin (Kuala Lumpur/MY)8
P
Tudor-Constantin Pörner (Jena/DE)
10
R
Tuomas Rissanen (Joensuu/FI)
Harald Rittger (Fürth/DE)
Mark Rosenberg (Kiel/DE)
9, 11
8, 11
9, 10, 11
S
Bruno Scheller (Homburg/DE)
Eun-Seok Shin (Ulsan/KR)
Ulrich Speck (Berlin/DE)
8, 10
11, 12
9, 10
8, 13
T
Gunnar Tepe (Rosenheim/DE)
12
U
Madlen Uhlemann (Leipzig/DE)
9
W
Wan Azman Wan Ahmad
(Kuala Lumpur/MY)
Michael Werk (Berlin/DE)
Z
Thomas Zeller (Bad Krozingen/DE)
10, 11
12
12
One Device. Two Technologies.
One
Device.
Two
Technologies.
AngioSculpt®X
catheter
is the
only device
you need for both plaque scorin
ne The
Device.
Two
Technologies.
in challenging
coronary
casesyou
such
asfor
ISR.both plaque scoring and drug delivery
AngioSculpt®X
catheter is
the only device
need
The AngioSculpt®X catheter is the only device you need for both plaque scoring
hallenging coronary cases such as ISR.
and drug delivery in challenging coronary cases such as ISR.
Visit us at booth n.34
us atn.34
booth n.3
sit us atVisit
booth
©2016 Spectranetics. All rights reserved. Approved for external distribution in EU only. AngioSculptX is not approved for distribution in the US. D031426-00 092016
anetics. All rights reserved. Approved for external distribution in EU only. AngioSculptX is not approved for distribution in the US. D031426-00 092016
©2016 Spectranetics. All rights reserved. Approved for external distribution in EU only.
AngioSculptX is not approved for distribution in the US. D031426-00 092016
B.Braun Anzeige
Interventional
Vascular
Diagnostics
and Therapy
YOUR SOLUTION-ORIENTED
PRODUCT CONCEPT FOR
A POLYMER-FREE ANGIOPLASTY
A-VS16004
B. Braun Melsungen AG | Vascular Systems | Sieversufer 8 | 12359 Berlin
Phone +49 30 568 207-300 | [email protected] | www.bbraun.de